Mark Sirgo

Mark Sirgo

Algemeen Directeur bij
Corium Pharma Solutions, Inc.
72 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Mark A. Sirgo was the founder of Arius Pharmaceuticals, Inc., founded in 2003, where the title held was Chief Executive Officer in 2004.
Current jobs include President, Chief Executive Officer & Director at Corium Innovations, Inc. since 2023, and Chairman at RDD Pharma Ltd. since 2018.
Former jobs include Chief Executive Officer & Director at Aruna Bio, Inc.; Vice Chairman at BioDelivery Sciences International, Inc. from 2018 to 2022; Chairman at 9 Meters Biopharma, Inc. from 2020 to 2023; Chairman at Genenta Science SpA; Independent Director at Biomerica, Inc. from 2016 to 2022; Independent Director at Salix Pharmaceuticals Ltd. from 2011 to 2015; Senior Vice President-Global Sales & Marketing at Pharmaceutical Product Development LLC from 1996 to 1999; Vice President-New Product Marketing at GSK Plc, Glaxo Wellcome, Inc., and Glaxo, Inc. Education includes undergraduate studies at The Ohio State University and a doctorate from Philadelphia College of Pharmacy.

Actieve functies van Mark Sirgo

BedrijvenFunctieBegin
Voorzitter 04-06-2018
Algemeen Directeur 17-01-2023

Eerdere bekende functies van Mark Sirgo

BedrijvenFunctieEinde
9 METERS BIOPHARMA, INC. Voorzitter 17-07-2023
BIOMERICA, INC. Directeur/Bestuurslid 07-12-2022
BIODELIVERY SCIENCES INTERNATIONAL, INC. Algemeen Directeur 02-01-2018
SALIX PHARMACEUTICALS, LTD. Directeur/Bestuurslid 01-04-2015
Algemeen Directeur 01-08-2004
Ervaring van Mark Sirgo in detail bekijken

Opleiding van Mark Sirgo

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

52

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit15

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Glaxo, Inc.

Health Services

Health Technology

Consumer Services

Electronic Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Mark Sirgo
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU